4 Steps

Sign in to view your progression
Programme overview Progr...
Learning objectives Learn...
Target audience Targe...
Abbreviations Abbre...

This programme covers essential knowledge for healthcare professionals in the field, and is intended for teaching purposes, to give an introduction to the key aspects of lipidology, in conjunction with one of the Society's face-to-face courses.

The programme's 4 modules each comprise 

  • 1 presentation,  ca. 20-30 minutes duration 
  • 2-3 post-presentation questions

Participants in this Programme will improve their understanding of the role of lipids in health and disease on several different levels. These different levels include:

  • basic understanding of lipids chemistry and lipoprotein metabolism
  • the role of lipids as risk factors
  • the mechanisms of lipids in cardiovascular disease
  • understanding of lipid disorders and the role of genetics and environmental factors
  • pharmacological interventions against lipid disorders
  • the clinical development of lipids
  • lipid-lowering treatment in cardiovascular prevention and the development of new therapeutic targets

Understanding the role of lipids in health and disease is important for a broad spectrum of different professionals working in health care and in society at large. This educational programme is suited to scientists working in cardiovascular epidemiology and in basic cardiovascular research, and persons employed in the pharma industry.

Others who may find the programme relevant include: physicians in internal medicine, cardiology, diabetology, endocrinology and in general practice; nurses working in lipid clinics, in cardiovascular prevention, in diabetes and in many other clinics training care of patients with cardiovascular or metabolic diseases.

ACLF - Acute on Chronic Liver Failure
Acrp30 - Adiponectin
ACS - Acute Coronary Syndrome
ADA - American Diabetes Association
ADMA - asymmetrical dimethylarginine
AGE - Advanced glycation end product
AGEs - Advanced Glycation Endproducts
AGI - Alpha Glucosidase Inhibitors
alpha 2-beta AR - alpha 2-beta adrenergic receptors
ALT - Alanine Aminotransferase
AMPK - Adenosine Monophosphate activated Protein Kinase
apM1 - Adiponectin
ARB - Angiotensin Receptor Blocker
ATP III - Adult Treatment Panel
BAD - Brachial Artery Distensibility
BCDI - Beta-Cell Demand Index
BCS - Budd-Chiari Syndrome
BDA - British Diabetic Association
BIP - Bezafibrate Infarction Prevention
BMI - Body Mass Index
CAD - Coronary Artery Disease
cccDNA - closed circular DNA
CCK - Cholecystokinin
CHD - Coronary Heart Disease
CHF - Congestive Heart Failure
CLA - Conjugated Linoleic Acid
CNTF - Ciliary Neurotrophic Factor
CRP - C reactive protein
CVD - cardiovascular disease
DASIMAR - the summed product of ADMA and SDMA
DASIMAR - score
DASIMAR - score of the sum of DAS and IMAR
DKA - Diabetic Ketoacidosis
DM - diabetes mellitus
DPP - Diabetes Prevention Program
EBL - Endoscopic band ligation
EGIR - European Group for the study of Insulin Resistance
EWET - Enlarged Waist with Elevated Triacylglycerols
FA - Fatty Acid
FAAH - Fatty Acid Amide Hydrolase
FBG - fasting blood glucose
FDA - Food and Drug Agency
FFAs - Free Fatty Acids
FIAF - Fasting Induced Adipose Factor
FMD - Flow-Mediated Dilation
FPG - fasting plasma glucose
FPI - Fasting Plasma Insulin
GI - Glycemic Index
GIK Therapy - Glucose-Insulin-Potassium Therapy
HbA1c - Glycosylated Hemoglobin A1C
HDL - high-density lipoprotein
HMO - Health Maintenance Organization
HOMA - Homeostasis Model Assessment
HPA - Hypothalamic-Pituitary-Adrenal
HRS - hepatorenal syndrome
HVPG - hepatic venous pressure gradient
IAPP - islet amyloid polypeptide
ICCU - Intensive Cardiac Care Unit
IDF - International Diabetes Federation
IFH - isolated fasting hyperglycemia
IGR - impaired glucose regulation
IGT - impaired glucose tolerance
IL-6 - Interleukin-6
IMCL - Intramyocellular Lipids
IMT - Intima-media Thickness
IPH - isolated postchallenge hyperglycemia
IPMN - intraductal papillary mucinous neoplasm
LDL - low-density lipoprotein
LDLT - Living donor liver transplantation
MGSD - Mediterranean Group for the Study of Diabetes
MI - Myocardial Infarction
NCEP - National Cholesterol Education Program
NGR - Normal glucose regulation
NGT - Normal glucose tolerance
NHS - Nurses' Health Study
OGTT - Oral Glucose Tolerance Test
PAI-1 - Plasminogen Activator Inhibitor Type 1
PGC-1 alpha - peroxisome proliferator-activated receptor gamma coactivator-1 alpha
PMN - Polymorphonuclear Neutrophil
PPAR gamma - peroxisome proliferator activated receptors
PPG - Postprandial Glucose
PSA - Prostate specific antigen
PWV - Pulse Wave Velocity
PWV - Pulse Wave Velocity
QOL - Quality of life
RAGE - Receptor for AGE
RAI - Radioactive iodine
RAI Scanning - Radioactive Iodine Scanning
RECIST - Response Evaluation Criteria In Solid Tumors
RNAi - RNA interference
RR - Relative risk
RXR - retinoid X receptors
SAA - Serum Amyloid A
SADLE - San Antonio Diabetes Likelihood Equation
SCL - Sclerotherapy
SDMA - symmetric dimethylarginine
SIRS - Systemic inflammatory response syndrome
SOFA - Sepsis-related Organ Failure Assessment
SU - sulfonylurea
T2D - type 2 diabetes
T4/T3 - Thyroxine
TERalb - Transcapillary Escape Rate of Albumin
TG - triglyceride
TIPS - Transjugular intrahepatic portosystemic shunt
TNF-alpha - Tumor Necrosis Factor alpha
TZD - Thiazolidinedione
UCP2 - Uncoupling Protein 2
VIP - Vasterbotten Intervention Program
VSMC - Vascular Smooth Muscle Cells
WC - Waist Circumference
WHO - World Health Organization

Lessons from epidemiology and environmental CVD risk factors
Overview of the role of lipids in atherosclerosis
Genetic disorders of lipid metabolism – with special focus on familial hypercholesterolaemia
New & old lipid-lowering drugs

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies